Marcos Gómez-Revuelta
0000-0002-3749-3801
19 papers found
Refreshing results…
Metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort
Pattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort
Prolactin, metabolic and immune parameters in naïve subjects with a first episode of psychosis
Stability of schizophrenia diagnosis in a 10‐year longitudinal study on first episode of non‐affective psychosis: Conclusions from the PAFIP cohort
Long-term clinical and functional outcome after antipsychotic discontinuation in early phases of non-affective psychosis: Results from the PAFIP-10 cohort
Aripiprazole vs Risperidone for the acute-phase treatment of first-episode psychosis: A 6-week randomized, flexible-dose, open-label clinical trial
Comparison of aripiprazole and risperidone effectiveness in first episode non-affective psychosis: rationale and design of a prospective, randomized, 3-phase, investigator-initiated study (PAFIP-3)
Understanding sex differences in long-term outcomes after a first episode of psychosis
A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients
Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort
Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis in the PAFIP 10-year follow-up program
Duration of active psychosis during early phases of the illness and functional outcome: The PAFIP 10-year follow-up study
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone
Apnea during slow sub-anaesthetic infusion of intravenous ketamine for treatment-resistant depression
Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis
Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients
Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort
Long-term antipsychotic effectiveness in First Episode of Psychosis: a 3-year follow-up randomized clinical trial comparing aripiprazole, quetiapine and ziprasidone
Duration of active psychosis and functional outcomes in first-episode non-affective psychosis
Missing publications? Search for publications with a matching author name.